Clinical Trials
7 trialsNCT06651970 2026-05-18
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
AstraZeneca
Phase 4 Recruiting
NCT06031233 2026-03-30
MINUTE
Isala
Phase 4 Recruiting
NCT07355699 2026-01-21
Application of Orelabrutinib With or Without CD20 Monoclonal Antibody in Previously Untreated Marginal Zone Lymphoma
Beijing Tongren Hospital
Phase 4 Recruiting
NCT07270835 2025-12-08
Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
The First Affiliated Hospital of Soochow University
Phase 4 Recruiting
NCT04989491 2024-08-19
REPLY
University Hospital, Strasbourg, France
Phase 4 Recruiting
NCT06134284 2024-06-11
Clinical Study of OR for Second-line Treatment of Refractory MZL
Ningbo No. 1 Hospital
Phase 4 Recruiting
NCT06410833 2024-05-16
BRRPJS
Peking Union Medical College Hospital
Phase 4 Recruiting